Season 301 Episode 10197
S2 E34 - Affordable Cancer Detection for All: The Mission of 20/20 GeneSystems
Jonathan Cohen Leads a Groundbreaking Effort to Democratize Life-Saving Cancer Testing and Investment Opportunities Through Innovation and Equity Crowdfunding http://s4g.biz/28nov24 tl;dr: Jonathan Cohen’s company offers one of only two multi-cancer early detection tests available today. 20/20 GeneSystems’ OneTest uses protein biomarkers, providing an affordable alternative to DNA-based diagnostics. The company’s equity crowdfunding campaigns align with its mission of democratizing access to biotech investments. During the COVID-19 pandemic, 20/20 GeneSystems pivoted quickly to become an early leader in testing. Jonathan’s innovative approach integrates AI and machine learning, modernizing cancer detection and expanding accessibility. http://superpowers4good.com #ImpactCrowdfunding #DiverseFounders #SocialEntrepreneurs #CommunityCapital #ImpactInvestors #RIC #InvestmentCrowdfunding #businessgrowth #endcancer
